Drug Pipeline

Toripalimab Injection Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
6
Active Studies
3
Recruiting
1
Phase 3
5
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2
2
Phase 1/2
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07445295 Chiauranib Plus PD-1 Inhibitor, Albumin-paclitaxel and Gemcitabine in Patients With… Metastatic Pancreatic Ductal Adenocarcinoma Not Yet Recruiting
Phase 2
NCT07314723 9MW2821 Combined With Toripalimab in Perioperative Patients With Urothelial Cancer Urothelial Carcinoma Recruiting
NCT06378177 A Study of LVGN6051 Combination Therapy in Patient With Head and Neck Squamous Cell… Head and Neck Squamous Cell Carcinoma Active, Not Recruiting
Phase 1/2
NCT07281976 A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative… Triple Negative Breast Cancer Recruiting
NCT07099430 A Trial of LBL-024 Monotherapy, LBL-024 Combined With LBL-007 or Toripalimab in Patients… Advanced Melanoma Recruiting
NCT07508761 IPG7236 Combined With Toripalimab in Participants With Advanced Solid Tumors Advanced Solid Tumor Not Yet Recruiting
Sponsors Running Toripalimab Injection Trials
Disease Areas
Get alerts when Toripalimab Injection trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free